Article Text
Abstract
INTRODUCTION
The term paraneoplastic syndrome is now mainly reserved for non-metastatic manifestations of cancer that are considered to have some immunological explanation, i.e. they are not due to vascular disease, coagulopathy, infection, metabolic disorder, nutritional deficeincy or the complications of treatment. The frequency of neurological paraneoplastic syndromes is something less than 0.5 per 100 000 population per year. Over the last 10 years, there has been increasing understanding of their immunological mechanisms and many new antigens/antibodies have been described. It is likely that the next few years will see the description of even more and so the number of ‘antibody negative’ cases will continue to shrink.
PATHOGENESIS
The central theory of pathogenesis is that the syndromes are autoimmune in origin. The individual patient mounts an antibody response to one or more of their tumour antigens, and the antibodies produced cross react with molecular domains normally expressed on neurones. (Fig. 1).
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Other content recommended for you
- A rare case of long - term paraesthesia diagnosed as a paraneoplastic syndrome by anti-SOX1 antibody determination
- Republished: Which antibody and which cancer in which paraneoplastic syndromes
- Which antibody and which cancer in which paraneoplastic syndromes
- Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease
- Cerebrospinal fluid study in paraneoplastic syndromes
- Paraneoplastic neurological syndrome as an initial indicator of small cell carcinoma of the lung
- Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases
- Delayed onset of a second paraneoplastic neurological syndrome in eight patients
- Paraneoplastic cerebellar degeneration diagnosed by anti-Yo determination in a young woman with early breast cancer
- Severe parkinsonism associated with anti-CRMP5 antibody - positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia